Back to results

print
Prepandemic H5N1 influenza vaccines

Source agency:
AETSA
Date of Submission:
19/01/2010
Date of Printing:
05/02/2012
Technology name:
Bk-PifaTM, HokkenTM, Fluval H5N1TM, PanfluTM, PrepandrixTM
Technology - type(s):
Drug
Patient indications:
SAGE recommendations [1]:
Strongly recommended: Persons should not carry out their functions unless they
are vaccinated.
Recommended: Persons are encouraged to be vaccinated.
May be made available: Responsible authorities should assess whether licensed
human H5N1 influenza vaccines might be made available,
without encouraging persons to be vaccinated. This does
not imply that vaccine should be provided free of charge.